Equity Research Report

Transchem Share Price Rally: Revenue Zero Hone Ke Baad Bhi Stock Kyu Bhaag Raha Hai?

Transchem Limited haal hi me stock market investors ke beech kaafi charcha ka vishay bani hui hai. Iski sabse badi wajah company ke share price me dekhne ko mili...

Mercury Laboratories Analysis: Revenue Growth Zero, Pharma Stock Me Kya Hai Risk?

Mercury Laboratories Limited ek established pharmaceutical company hai jo gynecology aur pediatrics segment ki medicines manufacture karti hai....

CCME Global Analysis: Company Ya Jaal? Investors Ke Liye Badi Warning

CCME Global haal hi me investors ke beech kaafi charcha ka vishay bana hua hai. Share price me...

Albert David Profit Ka Khel? Core Business Kamzor, Other Income Se Positive Bottom Line!

Albert David Ltd ke latest financial results ek mixed picture present karte hain. Pehli nazar me company ka...

Sakuma Exports Analysis: Sales Giri, EBITDA Margin 0% Ke Paas Opportunity Ya Red Flag?

Recent quarters me Sakuma Exports Share Analysis investors ke liye kaafi interesting aur saath hi concern wala topic...
spot_img

Gufic Biosciences Profile: Leading Lyophilized Injection Manufacturer in India

Gufic Biosciences Limited (GBL) is a prominent global pharmaceutical company offering a wide spectrum of pharmaceutical products and services. Backed by a strong distribution...

Infrastructure: The Backbone of India’s $5 Trillion Economy Ambition

Infrastructure has always been regarded as the backbone of economic progress. For India, it is not just a sector—it is the foundation upon which...

Piramal Pharma: A Re-Emerging Pharma Player with Strong Growth Ambitions

Piramal Pharma Limited (PPL), a part of the Piramal Group, operates across three key segments: Contract Development and Manufacturing Organization (CDMO), Complex Hospital Generics (Critical Care),...

Cement Sector Consolidation: Ambuja Acquires Majority Stake in Orient Cement

Ambuja Cements has acquired a 37.8% stake in Orient Cement, marking a significant consolidation move in the Indian cement industry. The acquisition was executed through...

Mankind Pharma Levels Up: ₹12,000 Cr Revenue, ₹8,500 Cr Debt – What’s the Strategy?

Mankind Pharma has crossed a market capitalization of ₹1.05 lakh crore. The company continues to post consistent sales growth, and its EBITDA margins have...

Sectoral Breakouts: The Next Leaders of This Bull Market!

📊 Sectoral Breakout Alert!Several key sectors in the Indian stock market are showing signs of strong bullish momentum. Chart patterns and rising volumes suggest...
spot_img
WhatsApp chat